Abstract
The incorporation of covalent fluorine has been widely used as an effective strategy in medicinal chemistry for drug discovery. The introduction of fluorine into a molecule can significantly influence conformation, lipophilicity, pKa, metabolism, and pharmacokinetic properties. In 1955, the first fluorinated drug fludrocortisone has been approved in the market for the treatment of the adrenogenital syndrome, postural hypotension, and adrenal insufficiency. Since then, 218 small-molecule drugs with at least one fluorine atom have been launched by U.S. FDA by the end of 2018. Therefore, this chapter is expected to summarize the fluorine-containing natural products in clinical development to the medicinal chemistry community.
Keywords: Antiproliferative, Antiviral, Anti-inflammatory, Clinical Development, Drug Discovery, Fluorinated Drug, Medicinal Chemistry, Natural Product, Nucleosides, Small-molecule, Steroids.
Related Journals
Current Drug Delivery
Current Bioactive Compounds
Current Drug Safety
Reviews on Recent Clinical Trials
Drug Delivery Letters
Recent Advances in Drug Delivery and Formulation
Recent Advances in Anti-Infective Drug Discovery
Drug Metabolism and Bioanalysis Letters
Applied Drug Research, Clinical Trials and Regulatory Affairs
Applied Clinical Research, Clinical Trials and Regulatory Affairs
Related Books
A Comprehensive Text Book on Self-emulsifying Drug Delivery Systems
Angiogenesis & Therapeutic Targets In Cancer
Anti-Angiogenesis Drug Discovery and Development
Anti-Angiogenesis Drug Discovery and Development
Anti-Angiogenesis Drug Discovery and Development
Anti-Angiogenesis Drug Discovery and Development
Anti-Angiogenesis Drug Discovery and Development
Biopolymers In Drug Delivery: Recent Advances and Challenges
Chemoinformatics: Directions Toward Combating Neglected Diseases
Current Advances in Drug Delivery Through Fast Dissolving/Disintegrating Dosage Forms